TheraVet (ISIN code: BE0974387194 – mnemonic: ALVET), a pioneering biotechnology company in the treatment of osteoarticular diseases in pets, today announces the signing of an exclusive distribution agreement with Vetpharma, a leading company in the commercialization of veterinary products and services. This agreement represents a significant step forward for the distribution of the BIOCERA-VET® product line, now available on five continents.
Thanks to this agreement with Vetpharma, BIOCERA-VET® will be distributed in Scandinavia (ie, Norway, Sweden, Denmark and Finland), in Eastern Europe (ie, Poland, Bulgaria, Romania, Czech Republic, Croatia and Hungary), in Latin America (ie, Brazil, Mexico, Colombia, Argentina, Chile and Peru), in South Africa, Australia and in certain Asian countries (ie, Japan, Indonesia, Philippines, Vietnam, Thailand and South Korea) .